| |
| |
|
| Insider
Information: |
Klein Joseph III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
86,717 |
|
|
Indirect Shares
|
111 |
|
|
| Direct
Value |
$3,780,675 |
|
|
|
Indirect Value
|
$3,922 |
|
|
| Total
Shares |
86,828 |
|
|
| Total
Value |
$3,784,597 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
3
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-3.0
|
| Percentage
Gain/Loss : |
 127.5%
|
 -75.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
as of May 22, 2007 |
2007-05-23 |
0 |
2003-09-11 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2010-03-08 |
35,000 |
2007-03-07 |
0 |
Premium* |
|
|
Clinical Data Inc |
CLDA |
Former Director |
2006-10-11 |
1,000 |
|
0 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2024-05-03 |
16,346 |
2024-05-03 |
100 |
Premium* |
|
|
Savient Pharmaceuticals Inc |
SVNTQ |
Director |
2010-06-08 |
17,388 |
2006-06-01 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2009-11-04 |
16,983 |
2009-11-04 |
11 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-05-15 |
4 |
A |
$12.77 |
$41,847 |
D/D |
3,277 |
48,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
47,500 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-03-30 |
4 |
A |
$12.02 |
$3,738 |
D/D |
311 |
45,527 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-12-29 |
4/A |
A |
$11.21 |
$3,744 |
D/D |
334 |
45,216 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
45,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-09-29 |
4 |
A |
$6.51 |
$3,750 |
D/D |
576 |
44,882 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-09-15 |
4 |
AB |
$6.30 |
$18,900 |
D/D |
3,000 |
44,306 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-03-05 |
4 |
B |
$10.07 |
$50,363 |
D/D |
5,000 |
42,500 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-09-01 |
4 |
AB |
$6.50 |
$19,494 |
D/D |
3,000 |
41,306 |
2.39 |
- |
|
| PDLI |
PDL Biopharma Inc |
Director |
– • – |
2009-11-04 |
4 |
OE |
$6.89 |
$165,456 |
D/D |
24,000 |
40,983 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2008-02-29 |
4/A |
OE |
$14.21 |
$426,300 |
D/D |
30,000 |
40,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2008-02-29 |
4 |
OE |
$14.21 |
$426,300 |
D/D |
30,000 |
40,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-08-15 |
4 |
AB |
$5.79 |
$17,370 |
D/D |
3,000 |
38,306 |
2.39 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2005-03-11 |
4 |
B |
$11.05 |
$110,512 |
D/D |
10,000 |
38,100 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-03-03 |
4 |
B |
$10.56 |
$52,818 |
D/D |
5,000 |
37,500 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-08-01 |
4 |
AB |
$5.88 |
$17,640 |
D/D |
3,000 |
35,306 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2010-03-08 |
4 |
S |
$22.12 |
$221,227 |
D/D |
(10,000) |
35,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-02-24 |
4 |
B |
$12.08 |
$120,784 |
D/D |
10,000 |
32,500 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-07-18 |
4 |
AB |
$5.19 |
$15,570 |
D/D |
3,000 |
32,306 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2006-08-09 |
4 |
OE |
$7.72 |
$231,600 |
D/D |
30,000 |
30,000 |
|
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2008-03-03 |
4 |
S |
$38.00 |
$380,333 |
D/D |
(10,000) |
30,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-07-03 |
4 |
AB |
$5.34 |
$16,020 |
D/D |
3,000 |
29,000 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2007-06-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
28,804 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
Director |
– • – |
2005-03-10 |
4 |
B |
$11.27 |
$171,012 |
D/D |
15,000 |
28,100 |
2.39 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
Director |
– • – |
2006-06-30 |
4 |
A |
$5.25 |
$1,607 |
D/D |
306 |
26,306 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
